Search for a trial

Encorafenib/binimetiib master protocol: an open-label continuation study for participants continuing from encorafenib/binimetinib clinical studies. ;Sub-study 1:
An open-label study for continued treatment access for participants from the C4211001 (Array CMEK162X2201) and the C4211003 (Array-162-311, MILO) Binimetinib studies.;Sub-study 2:
An open-label study for continued treatment access for participants from the C4221004 (Array CMEK162B2301, Columbus) Encorafenib and Binimetinib study;Sub-s

This study has been transitioned to CTIS with ID 2023-509408-13-00 check the CTIS register for the current data. - To monitor the safety and tolerability of binimetinib- To monitor the safety and tolerability of encorafenib